Biotech Firm Redx Eyes Delisting From London Market
Redx Pharma PLC proposed on Tuesday that it would cancel trading in its shares on the London Stock Exchange and re-register as a private business, citing constraints on market liquidity and...To view the full article, register now.
Already a subscriber? Click here to view full article